Skip to content

Effect of esketamine used in thoracoscopic lung surgery on inflammatory indicators in exhaled breath condensate of ventilated lung

Effect of esketamine used in thoracoscopic lung surgery on inflammatory indicators in exhaled breath condensate of ventilated lung

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042622
Enrollment
Unknown
Registered
2021-01-24
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thoracoscopic lung surgery

Interventions

control group:Nil
esketamine group:After anesthesia induction, the patients received intravenous injection of 0.1mg/kg ketamine, and then continuous intraoperative intravenous infusion of 0.1mg/kg/h esketamine until th

Sponsors

The Second Affiliated Hospital of Nantong University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 to 65 years; 2. ASA I-III; 3. Lung tumor surgery under endotracheal intubation under general anesthesia is planned, including wedge resection, segmental resection, partial pulmonary resection, lobectomy, and unilateral radical resection of lung cancer; 4. Plan to stay in hospital >= 48 hours after surgery.

Exclusion criteria

Exclusion criteria: 1. A history of allergy to ketamine or contraindications to its use (severe risk of elevated blood pressure and intracranial pressure, poorly controlled or untreated hypertension, untreated or undertreated hyperthyroidism, gastrointestinal bleeding); 2. Have mental illness and other chronic pain or other conditions that may confuse the analgesic reaction; 3. Unable to read and write Chinese, communication barriers; 4. Emergency surgery or trauma patients; 5. Previous history of thoracotomy or intraoperative knowledge;Additional intercostal incisions were needed during the operation. 6. Admitted to ICU after surgery; 7. Refuse to attend.

Design outcomes

Primary

MeasureTime frame
Inflammatory factors and oxidative stress indicators;

Secondary

MeasureTime frame
Airway resistance after single lung ventilation;pulmonary compliance;The incidence of hypoxemia;

Countries

China

Contacts

Public ContactBoxiang Du

The Second Affiliated Hospital of Nantong University

boxiang_du@163.com+86 15262839991

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026